US Court Dismisses Viatris EpiPen Suit, But Further Action Possible

Antitrust Suit Dismissed Without Prejudice

 
• By Dean Rudge
  
Gavel Law Red Background
Pfizer has just settled antitrust claims over EpiPen • Source: Alamy

More from Legal & IP

More from Generics Bulletin